Animal use reporting: 2019-2022, Waeterloos, Geneviève, and Ribaucour F , Annual OMCL meeting 2024, Common OCABR vaccine session, 2024/05/17, Issue EDQM, Ohrid, North Macedonia, (2024)

Annual use reporting: overview 2019-2022, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2024-03-20, Issue EDQM, Strasbourg, France, (2024)

DTaP Potency testing: 3R's status, Waeterloos, Geneviève, Ribaucour F, Florens Morgane, and Vermeulen M. , 6th WHO-NNB Workshop, 2024/11/27, Issue WHO, Cairo, Egypt, (2024)

EU Annual report : batch release of human vaccines, Waeterloos, Geneviève, Van Molle Wim, Tesolin L., Ribaucour F, Florens Morgane, Masquelier F., Clouet S., Domicent C., Auquier J., Laurent F., et al. , 01/04/2024, Brussels, Belgium, p.261, (2024)

3R Reporting Overview, Waeterloos, Geneviève, and Ribaucour F , Annual OMCL meeting, Common OCABR session, 2023 06 09, Issue EDQM -Spanish OMCL, Madrid, Spain, (2023)

Animal use reporting 2019 - 2022, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2023 10 25, Issue EDQM, Strasbourg, France, (2023)

EU batch release procedure: Annual Report 2 - Batch Release of  Vaccines, Waeterloos, Geneviève, Auquier J., Domicent C., Cuignet L., Clouet S., Desmet N., Florens Morgane, Laurent F., Masquelier F., Ribaucour F, et al. , 2023 05 25, p.314, (2023)

Review of animal reporting tables 2019 - 2021, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2023 03 29, Issue EDQM, Strasbourg, France, (2023)

National perspectives on non-animal approaches for quality control and batch release testing of biologicals and the influence of WHO guidelines, Waeterloos, Geneviève, Florens Morgane, and Ribaucour F , https://www.nc3rs.org.uk/events/nc3rs-workshop-implementing-3rs-who-guidelines-understanding-impact-quality-control-and , 2022 03 02, Virtual conference, London, United Kingdom , (2022)

Workshop on implementation of single dilution assay for in vivo testing, Ribaucour, F, Florens Morgane, and Tesolin L. , Workshop on implementation of single dilution assay for in vivo testing, 22/11/2022, Brussels, Belgium, (2022)

How to implement trend analysis, Tesolin, L., Waeterloos Geneviève, Stradiot L., Ribaucour F, Auquier J., and Cuignet L. , Training Saudi Food and Drug Authority, (2021)

Establishment of single dilution assays for animal based potency determinations, Waeterloos, Geneviève, Tesolin L., Ribaucour F, and Delbrassinne Laurence , WHO Webinar: Establishment of a single dilution potency assay, (2020)

Validation of a new reference lot for the serology of an acellular pertussis vaccine, Stygelbout, V., Dobly Alexandre, Domicent C., Dubois E., Ribaucour F, and Waeterloos Geneviève , EUpert  Strain/Genomics, 0/0/2015, Issue Universitair Ziekenhuis Brussel,  WIV-ISP, (2015)

Implementation of the serological method for the potency testing for acellular Pertussis vaccine: user's view., Ribaucour, F , Alternatives to animal testing, 8/9/2011, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2011)

Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH)., Van Molle, Wim, Maes A., Ribaucour F, and Waeterloos Geneviève , Quality of medicines in a globalised world: dreams and reality, 15/10/2010, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, Number 99, Prague, Czech Republic, p.98 - 99, (2010)

Animal use reporting: 2019-2023, Waeterloos, Geneviève, and Ribaucour F , OCABR Advisory group meeting, 2024/10/25, Issue EDQM, Strasbourg, France, (0)